[HTML][HTML] COVID-19: Why does disease severity vary among individuals?

S Samadizadeh, M Masoudi, M Rastegar, V Salimi… - Respiratory …, 2021 - Elsevier
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
responsible for the current pandemic, coronavirus disease 2019 (COVID-19). While all …

COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study

JJ Manson, C Crooks, M Naja, A Ledlie… - The Lancet …, 2020 - thelancet.com
Background A subset of patients with severe COVID-19 develop a hyperinflammatory
syndrome, which might contribute to morbidity and mortality. This study explores a specific …

Five consecutive epidemiological waves of COVID-19: a population-based cross-sectional study on characteristics, policies, and health outcome

R Amin, MR Sohrabi, AR Zali, K Hannani - BMC infectious diseases, 2022 - Springer
Background This study was conducted with the intension of providing a more detailed view
about the dynamics of COVID-19 pandemic. To this aim, characteristics, implemented public …

Immune dysfunction following COVID-19, especially in severe patients

CY Song, J Xu, JQ He, YQ Lu - Scientific reports, 2020 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) has been spreading worldwide. Severe
cases quickly progressed with unfavorable outcomes. We aim to investigate the clinical …

Why do some people develop serious COVID-19 disease after infection, while others only exhibit mild symptoms?

M Ballow, CL Haga - The Journal of Allergy and Clinical Immunology: In …, 2021 - Elsevier
The year 2020 was a landmark year of a once-in-a-century pandemic of a novel coronavirus,
SARS-CoV-2 virus, that led to a rapidly spreading coronavirus disease (COVID-19). The …

Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia

L Lin, L Lu, W Cao, T Li - Emerging microbes & infections, 2020 - Taylor & Francis
ABSTRACT Coronavirus disease 2019 (COVID-19) is an infectious disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with droplets and contact …

Risk and protective factors for COVID-19 morbidity, severity, and mortality

J Zhang, X Dong, G Liu, Y Gao - Clinical reviews in allergy & immunology, 2023 - Springer
The outbreak of the coronavirus disease 2019 (COVID-19), caused by the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global …

Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview

A Gupta, H Marzook, F Ahmad - Clinical and experimental medicine, 2023 - Springer
The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes major
challenges to the healthcare system. SARS-CoV-2 infection leads to millions of deaths …

Risk factors and outcomes of COVID‐19 in New York City; a retrospective cohort study

M van Gerwen, M Alsen, C Little… - Journal of medical …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is a global pandemic and information on
risk factors for worse prognosis is needed to accurately identify patients at risk and …

[HTML][HTML] Post acute coronavirus (COVID-19) syndrome

V Chippa, A Aleem, F Anjum - 2021 - europepmc.org
Post Acute Coronavirus (COVID-19) Syndrome - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …